Darzalex Q3 2026 net sales reach $4.24 billion, reports Genmab

Go back to Darzalex Q3 2026 net sales reach $4.24 billion, reports Genmab

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026

October 13, 2026 6:22 AM EDT

Company Announcement

Net sales of DARZALEX® in the third quarter of 2026 totaled USD 4,239 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)

COPENHAGEN, Denmark; October 13, 2026 Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX... More